Floatz logo

Vinorelbine

Recurrent Chronic Lymphocytic Leukemia

OHSU Knight Cancer InstitutePhase 1Dormant
CC
41/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
81/ 100

Competitive context

29 Active assets in the Recurrent Chronic Lymphocytic Leukemia cohort.

Asset / SponsorPhaseRating
Fludarabine
Ohio State University Comprehensive Cancer Center
Phase 4BBB
Cyclophosphamide
Ohio State University Comprehensive Cancer Center
Phase 4BBB
PREDNISONE TABLETS
Zulfa Omer
Phase 4BB
Inno-206
Zulfa Omer
Phase 4BB
DEXAMETHASONE
Vitebsk Regional Clinical Cancer Centre
Phase 3BB

View all 50 →

Same molecule, other indications

Vinorelbine is also rated in:

HER2 positive breast carcinomaDormant
BBB
Indicative ·
74 / 100
View asset →
Recurrent Breast CarcinomaDormant
BBB
Indicative ·
72 / 100
View asset →
Hodgkins lymphomaDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →